CDK inhibitors: positive and negative regulators of G1-phase progression - PubMed (original) (raw)
Review
. 1999 Jun 15;13(12):1501-12.
doi: 10.1101/gad.13.12.1501.
Affiliations
- PMID: 10385618
- DOI: 10.1101/gad.13.12.1501
Free article
Review
CDK inhibitors: positive and negative regulators of G1-phase progression
C J Sherr et al. Genes Dev. 1999.
Free article
No abstract available
Similar articles
- Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
Chellappan SP, Giordano A, Fisher PB. Chellappan SP, et al. Curr Top Microbiol Immunol. 1998;227:57-103. doi: 10.1007/978-3-642-71941-7_4. Curr Top Microbiol Immunol. 1998. PMID: 9479826 Review. No abstract available. - Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D, Mahony D, Wills K, Lees E. Parry D, et al. Mol Cell Biol. 1999 Mar;19(3):1775-83. doi: 10.1128/MCB.19.3.1775. Mol Cell Biol. 1999. PMID: 10022865 Free PMC article. - Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Sangfelt O, et al. Oncogene. 1999 May 6;18(18):2798-810. doi: 10.1038/sj.onc.1202609. Oncogene. 1999. PMID: 10362250 - Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
Watanabe G, Pena P, Shambaugh GE 3rd, Haines GK 3rd, Pestell RG. Watanabe G, et al. Brain Res Dev Brain Res. 1998 Jun 15;108(1-2):77-87. doi: 10.1016/s0165-3806(98)00032-7. Brain Res Dev Brain Res. 1998. PMID: 9693786 - Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.
Kiyokawa H, Koff A. Kiyokawa H, et al. Curr Top Microbiol Immunol. 1998;227:105-20. doi: 10.1007/978-3-642-71941-7_5. Curr Top Microbiol Immunol. 1998. PMID: 9479827 Review. No abstract available.
Cited by
- The history and future of targeting cyclin-dependent kinases in cancer therapy.
Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. Asghar U, et al. Nat Rev Drug Discov. 2015 Feb;14(2):130-46. doi: 10.1038/nrd4504. Nat Rev Drug Discov. 2015. PMID: 25633797 Free PMC article. Review. - Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES. Kumar P, et al. Future Virol. 2009 Jan;4(1):79-91. doi: 10.2217/17460794.4.1.79. Future Virol. 2009. PMID: 25635182 Free PMC article. - Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.
Pan Y, Zhang Q, Tian L, Wang X, Fan X, Zhang H, Claret FX, Yang H. Pan Y, et al. Cancer Res. 2012 Apr 1;72(7):1890-900. doi: 10.1158/0008-5472.CAN-11-3472. Epub 2012 Feb 20. Cancer Res. 2012. PMID: 22350412 Free PMC article. - Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.
Ghelli Luserna Di Rorà A, Iacobucci I, Imbrogno E, Papayannidis C, Derenzini E, Ferrari A, Guadagnuolo V, Robustelli V, Parisi S, Sartor C, Abbenante MC, Paolini S, Martinelli G. Ghelli Luserna Di Rorà A, et al. Oncotarget. 2016 Aug 16;7(33):53377-53391. doi: 10.18632/oncotarget.10535. Oncotarget. 2016. PMID: 27438145 Free PMC article. - Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4.
Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer AL 3rd, Louie T, Chen I, Randolph S, Hahn WC, Staudt LM, Niesvizky R, Moore MA, Chen-Kiang S. Huang X, et al. Blood. 2012 Aug 2;120(5):1095-106. doi: 10.1182/blood-2012-03-415984. Epub 2012 Jun 20. Blood. 2012. PMID: 22718837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources